Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.
Epistemonikos ID: 63967f37c5904f01d15d054feb59256d48377e66
First added on: May 05, 2024